Literature DB >> 16998275

Histological features of intracranial germinomas not disappearing immediately after radiotherapy.

Satoshi Utsuki1, Hidehiro Oka, Yoshinori Tanizaki, Koji Kondo, Nobuyuki Kawano, Kiyotaka Fujii.   

Abstract

The histological features of germinomas were investigated to differentiate tumors which completely disappear immediately after irradiation and those that persist. Eighteen previously untreated patients underwent germinoma biopsy and irradiation or combined irradiation and chemotherapy. Four tumors were located only in the pineal gland, eight in the suprasellar region, two in multiple locations, one in the basal ganglia, and three in other regions. Histologically, the germinomas could be divided into type A found in 13 cases which consisted mainly of large neoplastic cells and small lymphocytes, the so-called two-cell pattern, and type B found in five cases which consisted predominantly of fibrous tissue and granulomatous reaction containing occasional neoplastic cells. Follow-up computed tomography or magnetic resonance imaging showed the enhanced mass lesion disappeared in all cases of type A germinomas within 1 month after treatment, but persisted in all cases of type B germinomas for at least 1 month. Type B tumors required up to 12 months to show complete radiographic resolution. Persistent germinomas consisted predominantly of fibrous tissue and granulomatous reaction containing occasional neoplastic cells.

Entities:  

Mesh:

Year:  2006        PMID: 16998275     DOI: 10.2176/nmc.46.429

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  5 in total

1.  Is biopsy needed to guide management for all patients with presumed intracranial ectopic germinomas.

Authors:  Chenglin Tian; Chuanqiang Pu; WeiPing Wu; Xusheng Huang; Senyang Lang; Shengyuan Yu; Jiatang Zhang; Dehui Huang; Shuxiang Cui
Journal:  J Neurooncol       Date:  2008-10-26       Impact factor: 4.130

2.  Inherent diagnostic and treatment challenges in germinoma of the basal ganglia: a case report and review of the literature.

Authors:  Anita Villani; Eric Bouffet; Susan Blaser; Barbara-Ann Millar; Cynthia Hawkins; Ute Bartels
Journal:  J Neurooncol       Date:  2008-03-26       Impact factor: 4.130

3.  Antibodies Against Hypothalamus and Pituitary Gland in Childhood-Onset Brain Tumors and Pituitary Dysfunction.

Authors:  Giuseppa Patti; Erika Calandra; Annamaria De Bellis; Annalisa Gallizia; Marco Crocco; Flavia Napoli; Anna Maria Elsa Allegri; Hanan F Thiabat; Giuseppe Bellastella; Maria Ida Maiorino; Maria Luisa Garrè; Stefano Parodi; Mohamad Maghnie; Natascia di Iorgi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-18       Impact factor: 5.555

4.  Pituitary and systemic autoimmunity in a case of intrasellar germinoma.

Authors:  Angelika Gutenberg; Jennifer J Bell; Isabella Lupi; Shey-Cherng Tzou; Melissa A Landek-Salgado; Hiroaki Kimura; Jack Su; Lefkothea P Karaviti; Roberto Salvatori; Patrizio Caturegli
Journal:  Pituitary       Date:  2009-05-26       Impact factor: 4.107

5.  PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes.

Authors:  Bin Liu; Yoshiki Arakawa; Ryuta Yokogawa; Shinya Tokunaga; Yukinori Terada; Daiki Murata; Yasuzumi Matsui; Ko-Ichi Fujimoto; Nobuyuki Fukui; Masahiro Tanji; Yohei Mineharu; Sachiko Minamiguchi; Susumu Miyamoto
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.